Company profile
Premark Pharma company profile
Premark Pharma develops pharmaceutical products that use pimecrolimus to treat inflammatory diseases of the skin, eye, mucosae and mucocutaneous surfaces. The company focuses on topical formulations and late-stage clinical development. Its pipeline includes products for chronic blepharitis and dry eye or ocular surface inflammation. Premark Pharma advances assets through Phase 2 and Phase 3 programmes and enters partnering agreements for further development and commercialisation.
Business identity
- Website
- https://premarkpharma.com
- Phone number
- +41 796 19 37 44
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2018-04-01, Month
Headquarters
- Headquarters
- Saint-Ursanne, Jura, Switzerland
- Postal code
- 4153
- Country code
- CH
- Continent
- Europe